Panakès Partners appoints partner to lead biotech investing

New partner Rob Woodman has 15 years of experience in life science investing in institutional and corporate VC.

Italian venture firm Panakès Partners, which recently closed on €150 million ($175 million) for its second fund, has named Dr. Rob Woodman as a partner to lead its newly created biotech investment team.

Panakès’ second fund, named the Purple Fund, is focused on biotech and medtech.

Prior to joining Panakès, Woodman was senior partner at Takeda Ventures and also head of Genesis Labs, Takeda R&D’s internal incubator, since 2018. Before that, he was a partner in the healthcare investment team at Touchstone Innovations (formerly Imperial Innovations) in London.  He started his venture career at Sofinnova Partners in Paris where he became principal in the life science team.

Source: Firm press release